Celsis IVT alleges patent infringement, files lawsuit against Sekisui Chemical substance and subsidiaries Celsis In Vitro, Inc. announced today that it provides filed a patent infringement lawsuit against XenoTech LLC, Sekisui Chemical substance Co. Ltd., and Sekisui Medical Co. Ltd. In the United States District Courtroom for the Northern District of Illinois in Chicago.S. Patent No. 7,604,929 . The ‘929 patent pertains to processes and options for producing cryopreserved hepatocytes.’.They attribute to it almost every drop in fertility and every averted birth: some 400m more folks, they claim, could have been born without it,’ an Economist editorial claims, adding, ‘This is patent nonsense. Chinese fertility was falling for decades before the one-child plan took effect in 1979.’ ‘The old leadership is definitely wedded to the one-child policy, however the brand-new leadership, which is because of take over next season, can think afresh. It should end this abomination as soon as it takes power,’ the Economist writes . This content was reprinted from kaiserhealthnews.org with permission from the Henry J.